TitleCav 1.3 L-type Ca ( 2+) channels mediate long-term adaptation in dopamine D2L-mediated GluA1 trafficking in the dorsal striatum following cocaine exposure.
Publication TypeJournal Article
Year of Publication2012
AuthorsSchierberl K, Giordano T, Satpute S, Hao J, Kaur G, Hofmann F, Moosmang S, Striessnig J, Rajadhyaksha A
JournalChannels (Austin)
Volume6
Issue1
Pagination11-7
Date Published2012 Jan-Feb
ISSN1933-6969
KeywordsAdaptation, Physiological, Animals, Calcium Channels, L-Type, Cocaine, Corpus Striatum, Dopamine Uptake Inhibitors, Gene Knockdown Techniques, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Mitogen-Activated Protein Kinase 1, Receptors, AMPA, Receptors, Dopamine D2, RNA, Messenger, Substance Withdrawal Syndrome
Abstract

AMPA receptor (AMPAR) plasticity at glutamatergic synapses in the mesostriatal dopaminergic pathway has been implicated in persistent cocaine-induced behavioral responses; however, the precise mechanism underlying these changes remains unknown. Utilizing cocaine psychomotor sensitization in mice we find that repeated cocaine results in a basal reduction of Ser 845 GluA1 and cell surface GluA1 levels in the dorsal striatum (dStr) following a protracted withdrawal period, an adaptation that is dependent on Cav 1.3 channels but not those expressed in the VTA. We find that the basally-induced decrease in this phosphoprotein is the result of recruitment of the striatal dopamine D2 pathway, as evidenced by enhanced levels of D2 receptor (D2R) mRNA expression and D2R function as examined using the D2R antagonist, eticlopride, as well as alterations in the phosphorylation status of several downstream molecular targets of D2R's, including CREB, DARPP-32, Akt and GSK3β. Taken together with our recently published findings examining similar phenomena in the nucleus accumbens (NAc), these results underscore the utilization of divergent molecular mechanisms in the dStr, in mediating cocaine-induced persistent behavioral changes.

DOI10.4161/chan.19324
Alternate JournalChannels (Austin)
PubMed ID22419037
PubMed Central IDPMC3367674
Grant ListT32 DA007274 / DA / NIDA NIH HHS / United States
W 1101 / / Austrian Science Fund FWF / Austria
DA007274-19 / DA / NIDA NIH HHS / United States
R21 DA023686 / DA / NIDA NIH HHS / United States
P 20670 / / Austrian Science Fund FWF / Austria
K01 DA14057 / DA / NIDA NIH HHS / United States
K01 DA014057 / DA / NIDA NIH HHS / United States